Amgen Inc. Public Float
Amgen Inc. (AMGN) had Public Float of $150.10 billion as of 2025-06-30, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-13
- 2025-06-30: Entity Public Float $150.10B.
- 2024-06-30: Entity Public Float $167.60B.
- 2023-06-30: Entity Public Float $118.56B.
- 2022-06-30: Entity Public Float $129.94B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $150.10B 10-K · filed 2026-02-13 |
| 2024-06-30 | $167.60B 10-K · filed 2025-02-14 |
| 2023-06-30 | $118.56B 10-K · filed 2024-02-14 |
| 2022-06-30 | $129.94B 10-K · filed 2023-02-09 |
| 2021-06-30 | $137.53B 10-K · filed 2022-02-16 |
| 2020-06-30 | $138.06B 10-K · filed 2021-02-09 |
| 2019-06-30 | $110.81B 10-K · filed 2020-02-12 |
| 2018-06-30 | $119.63B 10-K · filed 2019-02-13 |
| 2017-06-30 | $125.65B 10-K · filed 2018-02-13 |
| 2016-06-30 | $101.18B 10-K · filed 2017-02-14 |
| 2015-06-30 | $102.12B 10-K · filed 2016-02-16 |
| 2014-06-30 | $89.80B 10-K · filed 2015-02-19 |
| 2013-06-30 | $74.22B 10-K · filed 2014-02-24 |
| 2012-06-30 | $56.03B 10-K · filed 2013-02-27 |
| 2011-06-30 | $53.86B 10-K · filed 2012-02-29 |
| 2010-06-30 | $50.36B 10-Q · filed 2011-11-04 |
| 2009-06-30 | $53.67B 10-Q · filed 2010-11-08 |
| 2008-06-30 | $49.81B 10-Q · filed 2009-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |